Correction: High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs)

Suggested Citation

Kanjanasirirat P., Jearawuttanakul K., Seemakhan S., Borwornpinyo S., Wongtrakoongate P., Hongeng S., Charoensutthivarakul S. Correction: High-throughput screening of FDA-approved drugs identifies colchicine as a potential therapeutic agent for atypical teratoid/rhabdoid tumors (AT/RTs). Rsc Advances Vol.15 No.53 (2025) , 44991-44991. 44991. doi:10.1039/d5ra90136g Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116307

Availability

Collections